Bạn đang xem bản rút gọn của tài liệu. Xem và tải ngay bản đầy đủ của tài liệu tại đây (164.98 KB, 1 trang )
Intrathoracic tuberculosis (pulmonary parenchymal disease, intrathoracic lymphadenopathy, and
pleural disease) and peripheral lymphadenopathy account for over 90% of all cases of childhood
tuberculosis.
Most children with tuberculosis have negative acid-fast sputum smears and cultures; the diagnosis is
instead based on a triad of findings: a positive TST or TB blood test (interferon gamma release
assays [IGRAs]); compatible radiographic and clinical findings; and contact with a person known to
have tuberculosis disease.
Preadolescent children with pulmonary tuberculosis without cavitary findings on radiography rarely
are contagious; however, providers should utilize airborne precautions because in many instances,
the child is brought to the ED by the person from whom they acquired tuberculosis, and that adult is
by definition contagious.
Current Evidence
The most common sites of infection are intrathoracic (pulmonary parenchymal, intrathoracic adenopathy, and/or
pleural effusions) and peripheral lymphadenopathy. Together, these account for over 90% of all childhood TB
cases. Meningeal tuberculosis comprises 1% to 2% of all childhood TB cases, and is most common in children in
the first 2 years of life.
Latent tuberculosis infection (LTBI) is defined as a positive TST ( e-Table 94.16 ) or IGRA in a child who
lacks TB symptoms and has a normal chest radiograph and physical examination. While LTBI will rarely be an
ED-based diagnosis, clinicians may see children with LTBI for nontuberculosis concerns or for medication adverse
events. Children with LTBI are not contagious and have no specific infection control considerations. As most
tuberculosis medications are hepatically metabolized, the clinician should be aware of potential hepatotoxicity if a
child receiving tuberculosis medication presents with abdominal pain, vomiting, anorexia, or icterus. Isoniazid
(INH) can also cause peripheral neuropathy and can cause benzodiazepine-refractory seizures in cases of overdose
(the antidote is pyridoxine, administered as a gram-to-gram dose based on the estimates of the INH dose ingested).
Goals of Treatment
The goal of treatment is to recognize which children with pulmonary, meningeal, or lymphadenitis may have
tuberculosis as opposed to other diagnoses.
Clinical Considerations
Clinical recognition: Tuberculosis disease ( e-Table 94.17 ) should be included in the differential diagnosis of
children with fever of unknown origin; pneumonia refractory to therapy for community-acquired pneumonia;
cavitary pneumonia/lung abscesses; hilar or mediastinal adenopathy; miliary pattern on chest radiograph; freeflowing pleural effusions with or without consolidation; chronic nontender adenopathy; chronic otorrhea or